In the News

Recent Coverage of HMS in the News
September 12, 2012

Brigham and Women’s Hospital surgeons said at a news conference yesterday that the hospital has approved a patient for transplant surgery — the first double arm transplant above the elbow to be performed in the United States. Bohdan Pomahac, HMS associate professor of surgery at Brigham and Women’s Hospital, is quoted.

September 12, 2012

A centerpiece of Beth Israel Deaconess Medical Center’s IT-based innovation is a new medical informatics platform called Clinical Query, a search engine married to a huge database of patient records that lets hospital employees test hypotheses about what causes a disease, for instance, or test which drug, diet, or lifestyle variables may reduce the risk of developing one. John Halamka, CIO of Beth Israel Deaconess Medical Center and HMS professor of medicine, is quoted.

September 12, 2012

New research shows that talking to your doctor about a medication’s possible side effects — just hearing about the high blood pressure or abnormal vision — may increase the chance that you actually experience them. Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center and Arthur Barsky, HMS professor of psychiatry at Brigham and Women’s Hospital, spoke about this topic on Radio Boston.

September 11, 2012

Growing numbers of pregnant women are on medicines to treat high blood pressure, new research indicates. Brian Bateman, HMS assistant professor of anaesthesia at Massachusetts General Hospital, is an author of the study.

September 11, 2012

It may be more important than we thought to tackle obesity in childhood. A new study finds that overweight teenagers eat fewer calories than their healthy weight peers. Matthew Gillman, HMS professor of population medicine, is quoted.

September 11, 2012

New research suggests that close connections to friends and family may ward off poor health and premature death. A study by George Vaillant, HMS professor of psychiatry at Massachusetts General Hospital, is cited.

September 11, 2012

Johnson & Johnson and Pfizer Inc.’s bapineuzumab, an experimental drug that failed to help Alzheimer’s symptoms in a study, showed signs of reducing physical damage in the brain, according to a deeper analysis. Reisa Sperling, HMS professor of neurology at Brigham and Women’s Hospital, led one of the studies.

September 11, 2012

A pervading theme at a conference this week sponsored jointly by Pfizer Inc. and the Harvard Business School Health Industry Alumni Association was the growing trend toward partnerships between pharmaceutical companies and academia. Jeffrey S. Flier, dean of the faculty of medicine at HMS, is mentioned as a speaker at the conference.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.